Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

The eighth Arab-American Frontiers of Science, Engineering, and Medicine Symposium, co-organized by PNNL engineer and research line manager Leonard Pease, brought together multi-disciplinary researchers from around the globe.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

PNNL catalysis expert Yong Wang has assumed an associate editor role for the Chemical Engineering Journal.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

Fifteen female materials scientists and engineers have collaborated on a perspective of electrochemistry in battery design.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

A multi-institution team of researchers has developed a palladium-based catalyst that could clean emissions from natural gas engines.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

PNNL’s Jie Xiao and Yuyan Shao are serving two-year terms on the executive committee of the Pacific Northwest section of The Electrochemical Society, which was chartered in October 2020.

From water purification, to better batteries and tools to foil a cyberattack—a look back at how PNNL helped to invent a brighter and better future over the last year.

A multi-institutional team has obtained information about nanoscale interactions between the spike protein of the novel coronavirus SARS-CoV-2 and common household inorganic surfaces.

The Battery500 Consortium, led by PNNL, has been awarded $75 million for advancing battery technologies over the next five years.

PNNL is rock solid on carbon storage, building on successful demonstration in eastern Washington.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Developed at PNNL, Shear Assisted Processing and Extrusion, or ShAPE™, uses significantly less energy and can deliver components like wire, tubes and bars 10 times faster than conventional extrusion, with no sacrifice in quality.